本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Janux Therapeutics, Inc.

15.04
-0.2000-1.31%
盤前14.61-0.4300-2.86%08:57 EDT
成交量:98.76萬
成交額:1,470.90萬
市值:9.15億
市盈率:-8.20
高:15.13
開:14.68
低:14.60
收:15.24
52周最高:35.34
52周最低:12.12
股本:6,083.17萬
流通股本:4,168.06萬
量比:1.32
換手率:2.37%
股息:- -
股息率:- -
每股收益(TTM):-1.8336
每股收益(LYR):-1.8336
淨資產收益率:-11.48%
總資產收益率:-9.55%
市淨率:0.96
市盈率(LYR):-8.20

資料載入中...

2025/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/05

重要事件披露

Form 8-K - Current report
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report